Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania

Journal of Psychiatric Research

Volumn 45, Issue 2, 2011, Pages 162-168

  Jornada, Luciano K ^a   Valvassori, Samira S ^a   Steckert, Amanda V ^a   Moretti, Morgana ^a   Mina, Francielle ^a   Ferreira, Camila L ^a   Arent, Camila O ^a   Dal Pizzol, Felipe ^a   Quevedo, João ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Lithium; Mania; Ouabain; Oxidative stress; Submitochondrial particles; Valproate

Indexed keywords

ANTIOXIDANT; CATALASE; LITHIUM; OUABAIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE REGIMEN; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HIPPOCAMPUS; MALE; MANIA; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PSYCHOPHARMACOLOGY; RAT;

EID: 78650679896     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.05.011     Document Type: Article

References (37)

1. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126.
2. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. Journal of Affective Disorders 2008, 111:135-144.
3. Andreazza A.C., Kauer-Sant'Anna M., Frey B.N., Stertz L., Zanotto C., Ribeiro L., et al. Effects of mood stabilizers on DNA damage in an animal model of mania. Journal of Psychiatry and Neuroscience 2008, 33:516-524.
4. Angst F., Stassen H., Clayton P.J., Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. Journal of Affective Disorders 2002, 68:167-181.
5. Bannister J.V., Calabrese L. Assays for superoxide dismutase. Methods of Biochemical Analysis 1987, 32:279-312.
6. Belmaker R.H. Bipolar disorder. New England Journal of Medicine 2004, 351:476-486.
7. Bhalla P., Dhawan D.K. Protective role of lithium in ameliorating the aluminium-induced oxidative stress and histological changes in rat brain. Cellular and Molecular Neurobiology 2009, 29:513-521.
8. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods in Enzymology 1984, 105:429-435.
9. Boveris A., Oshino N., Chance B. The cellular production of hydrogen peroxide. Biochemical Journal 1972, 128:617-627.
10. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiological Reviews 1979, 59:527-605.
11. Chuang D.M., Chen R.W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disorder 2002, 4:129-136.
12. Decker S., Grider G., Cobb M., Li X.P., Huff M.O., El-Mallakh R.S., et al. Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2000, 24:455-462.
13. El-Mallakh R.S., El-Masri M.A., Uhf M.O., Li X.P., Decker S., Levy R.S. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disorder 2003, 5:362-365.
14. El-Mallakh R.S., Wyatt R.J. The Na, K-ATPase hypothesis for bipolar illness. Biological Psychiatry 1995, 37:235-244.
15. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods in Enzymology 1990, 186:407-421.
16. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proceedings of the Society for Experimental Biology and Medicine 1999, 222:236-245.
17. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. Journal of Neurochemistry 2006, 97:1634-1658.
18. Halliwell B., Gutteridge J.M. Free Radical in Biology and Medicine 1999, Oxford University Press, Oxford, UK.
19. Hamid H., Gao Y., Lei Z., Hougland M.T., El-Mallakh R.S. Effect of ouabain on sodium pump alpha-isoform expression in an animal model of mania. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:1103-1106.
20. Hammel K.E., Kapich A.N., Jensen K.A., Ryan Z.C. Reactive oxygen species as agents of wood decay by fungi. Enzyme and Microbial Technology 2002, 30:445-453.
21. Hesketh J.E., Glen A.I.M., Reading H.W. Membrane ATPase activities in depressive illness. Journal of Neurochemistry 1977, 28:1401-1402.
22. Jornada K.L., Moretti M., Valvassori S.S., Ferreira C.L., Padilha P.T., Arent C.O., et al. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. Journal of Psychiatric Research 2009.
23. Kapczinski F., Frey B.N., Andreazza A.C., Kauer-Sant'Anna M., Cunha A.B., Post R.M. Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Revista Brasileira de Psiquiatria 2008, 30:243-245.
24. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymology 1994, 233:346-357.
25. Li R., El-Mallakh R.S., Harrison L., Changaris D.G., Levy R.S. Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Molecular and Chemical Neuropathology 1997, 31:65-72.
26. 2 in aqueous solutions: implications for wood decay. Environmental Science and Technology 2005, 39:175-180.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
28. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser V., da Silva Vargas R., et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neuroscience Letters 2007, 421:33-36.
29. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504.
30. Naylor G.J., Smith A.I.I.W., Dick E.G., Dick D.A., McHarg A.M., Chambers C.A. Erythrocyte membrane cation carrier in manic-depressive psychosis. Psychological Medicine 1980, 10:521-525.
31. Reddy P.L., Khanna S., Subhash M.N., Channabasavanna S.M., Rao B.S. Erythrocyte membrane sodium-potassium adenosine triphosphatase activity in affective disorders. Journal of Neural Transmission 1992, 89:209-218.
32. Reddy R., Sahebarao M.P., Mukhergee S., Murthy J.N. Enzymes the antioxidant defense system in chronic schizophrenic patients. Biological Psychiatry 1991, 30:109-412.
33. Riegel R.E., Valvassori S.S., Elias G., Réus G.Z., Steckert A.V., de Souza B., et al. Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain. Neurochemistry International 2009, 55:491-495.
34. Ruktanonchai D.J., El-Mallakh R.S., Li R., Levy R.S. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiology and Behavior 1998, 63:403-406.
35. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 2005, 10:900-919.
36. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S., MacQueen G., McIntyre R., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorder 2005, 7:5-69.
37. Zaleska M.M., Floyd R.A. Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochemical Research 1985, 10:397-410.